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Disease modelling in human organoids
Madeline A. Lancaster1,* and Meritxell Huch2,3,4,*
ABSTRACT
The past decade has seen an explosion in the field of in vitro disease
modelling, in particular the development of organoids. These self-
organizing tissues derived from stem cells provide a unique system to
examinemechanisms ranging from organ development to homeostasis
and disease. Because organoids develop according to intrinsic
developmental programmes, the resultant tissue morphology
recapitulates organ architecture with remarkable fidelity. Furthermore,
the fact that these tissues can be derived from human progenitors
allows for the study of uniquely human processes and disorders.
This article and accompanying poster highlight the currently available
methods, particularly those aimed at modelling human biology, and
provide an overview of their capabilities and limitations. We also
speculate on possible future technological advances that have the
potential for great strides in both disease modelling and future
regenerative strategies.
KEY WORDS: Stem cells, Embryonic development, Regenerative
medicine, In vitro
Introduction
Organoids (see Box 1) are a powerful new system and are being
increasingly adopted for a wide range of studies. Indeed, since 2009,
over 3000 papers have been published that make use of organoids in
some form or another (see poster and Box 2). Organoids can be
derived either from pluripotent stem cells (PSCs), adult-tissue-resident
cells (stem or differentiated cells) or embryonic progenitors (Huch and
Koo, 2015). Because organoids follow the same basic intrinsic
patterning events as the organ itself, they are a useful tool for
investigating developmental organogenesis or processes of adult
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repair and homeostasis. Their more accurate organ-like organization
makes them a valuable tool for disease modelling, although further
improvements, particularly in scalability, are still needed.
Nonetheless, because organoids have such potential, extensive effort
has been made at generating organoids for a range of organ types. We
describe the methods and applications for these in more detail in this
article and in the accompanying poster, and discuss future directions
for improving this technology and furthering its applications.
Pluripotent stem-cell-derived and adult-tissue-derived
organoids
One of the major leaps that has led to the development of organoid
methods was the realization that, to better recapitulate organ
morphology in vitro, one must first understand the development of
that organ and try tomimic it. Thus, years of research on the patterning
events and signalling cascades at play during organogenesis have
provided the necessary foundation to make organoid research
possible. The relatively recent advent of human pluripotent stem cell
(PSC) cultures has provided the starting point for this process.
Remarkably, human PSCs can be induced to spontaneously
undergo differentiative and morphogenetic behaviours that mimic
the formation of embryonic germ layers, especially when they are
forced to form three-dimensional (3D) aggregates called embryoid
bodies (EBs; Box 3). EBs form germ layers that express well-described
molecular markers and even segregate to form patches of individual
germ-layer tissue within the aggregate. By applying specific growth
factors, these aggregates can be directed towards a specific germ layer.
Biologists have taken advantage of the knowledge on
developmental events to construct or reconstruct a tissue in vitro
(organoids) that recapitulates many of the key structural and
functional features of the organ (Box 1). The range of organoids
established so far is rapidly increasing, and although in many cases
these have been first developed from rodent PSCs, researchers are
translating experimental methods to human cells.
The use of PSCs as a starting point to generate 3D organoid
cultures allows the in vitro recapitulation of the developmental
processes and tissue organogenesis that occur in vivo. However,
once organ growth is terminated, adult tissues still require tissue
maintenance and repair to ensure proper functionality of the adult
organ. Recently, a better understanding of the signalling pathways
important for adult tissue maintenance and repair has enabled
researchers to grow primary tissues as self-expanding organoids that
retain all the characteristics of the tissue of origin, as well as their
genetic stability over time (see Huch and Koo, 2015 for an extended
review; Table 1).
Here, we summarize the methods for derivation of organoids
from human cells, be it PSCs or tissue-resident cells.
Endoderm-derived organoids
The development of 3D organoid cultures has proven very successful
for several endoderm-derived organs, such as the intestine, stomach,
liver, pancreas and lung. In this section, we discuss the findings and
conditions used to develop these organoids.
Box 1. Organoids: definition and applications
The term ‘organoid’ is actually not new. A simple PubMed search reveals
its first usage in 1946 in reference to a tumour case study (Smith and
Cochrane, 1946). However, at that time, the term was used to describe
certain histological features of tumours, such as glandular organization.
Over time, its meaning evolved to generally refer to tissues or structures
that resemble an organ, and so this term became increasingly used in
in vitro biology. However, it wasn’t until the development of intestinal
organoids in 2009 (Sato et al., 2009) that it began to be used more
specifically for these self-organizing in vitro structures. Nonetheless, the
term ‘organoid’ continues to be used for a wide variety of tissues or
structures that may or may not fully recapitulate key features of an organ.
Therefore, in an attempt to clarify some of the confusion surrounding
this term, we use a previously proposed working definition (Lancaster
and Knoblich, 2014; Huch and Koo, 2015; Clevers, 2016) that fulfils the
most basic definition; namely, ‘resembling an organ’. More specifically, a
genuine organoid should satisfy several criteria: (1) a 3D structure
containing cells that establish or retain the identity of the organ being
modelled; (2) the presence of multiple cell types, as in the organ itself; (3)
the tissue exhibits some aspect of the specialized function of the organ;
and (4) self-organization according to the same intrinsic organizing
principles as in the organ itself (Sasai, 2013a,b).
Box 2. Birth of the organoid field
Since the dawn of biology as a scientific field, scientists have sought to
understand mechanisms of human disease. While studying patients can
give insight into symptoms and help describe the course of the disease,
the underlying causes are often enigmatic. Therefore, animal models
have been a staple of human disease research, as they can be
engineered to develop the disease, for example, by introducing relevant
mutations. However, because of evolutionary divergence, there are
many features of human biology and disease mechanisms that cannot
be accurately modelled in animals. For instance, rodent models of
Alzheimer’s disease do not ubiquitously display the characteristic
plaques and tangles (Asaad and Lee, 2018). When key disease
features are absent from animal models, it is difficult to study the
underlying mechanisms.
For these reasons, efforts over the past several decades have
focused on modelling human disease biology in a dish. While HeLa cells
and other immortalized human cell lines have proven to be a powerful tool,
their use has several considerable drawbacks, including their genomic
instability and limited tissue identities (Adey et al., 2013). Furthermore, the
expansion of adult primary tissues far beyond the predictedHayflick limit is
a real challenge (Hayflick, 1965). Thus, more recent approaches have
focused on in vitro models derived from stem cells, which allow for a
broader array of tissue identities, long-term expansion, better genomic
integrity and improved modelling of healthy biology. A stem cell is any cell
that is able to self-renew and generate differentiated progeny, i.e. capable
of generating several defined identities. Thus, differentiated organ cell
types can be generated in vitro from pluripotent stem cells (PSCs) by
following a series of differentiation steps that mimic early embryonic
development. Alternatively, differentiated cells derived from resident adult
stem/progenitor cells, such as the stem cells of the intestinal crypt, can be
used but historically these have proven difficult to expand in vitro (Bjerknes
and Cheng, 2006).
In order to overcome these limitations and also better recapitulate
tissue architecture, a new field of 3D in vitro biology called tissue
engineering has come into the spotlight. By combining biology and
engineering, more elaborate conformations of cells have been
established, allowing for multiple cell types to be combined in a
configuration that more closely mimics organ architecture. Perhaps the
most exciting developments have been the recent organ-on-a-chip
methods, which allow for the construction of connected chambers that
mimic different organ compartments, for example liver ducts and blood
vasculature (Huh et al., 2011).
While tissue engineering has provided a number of highly useful
models for looking at the interaction between different cell types, there
are certain artificial aspects that affect their ability to accurately model
organ structure and therefore function. For example, the use of artificial
membranes and matrices means that the cells are positioned via
exogenous processes, rather than through bottom-up self-organizing
principles as in organ development in vivo. Thus, to more accurately
model organ architecture, very recent efforts have focused on supporting
the self-organizing development of these tissues in vitro. And so, the
organoid field was born.
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Intestinal organoids
In the intestine, Wnt, Notch, fibroblast growth factor (FGF)/
epidermal growth factor (EGF) and bone morphogenetic protein
(BMP)/Nodal signalling are required during tissue development
and in adult homeostasis and repair. By combining the knowledge
on stem-cell populations and on the intestinal stem-cell niche
requirements, intestinal organoids from either postnatal or adult
intestinal epithelium (Ootani et al., 2009) or from a single adult
intestinal stem cell (Sato et al., 2009) have been established, with an
expansion potential far beyond the Hayflick limit (>1 year in
culture). Similarly, mouse- and human-derived colonic stem cells
have also been expanded in organoid cultures with minor
adjustments in the medium composition (Sato et al., 2011). The
culture conditions that support intestinal organoids include
embedding the intestinal stem cells (or cells with the ability to
acquire stem-cell potential, i.e. immediate daughters of the stem
cells) in a 3D extracellular matrix (e.g. Matrigel) and culturing them
in a medium supplemented with EGF, noggin and the Wnt agonist
R-spondin (RSPO). These conditions allow the long-term
expansion of adult intestinal epithelium in culture while retaining
its ability to differentiate into individual derivatives (Sato et al.,
2011; Ootani et al., 2009).
In parallel studies, the Wells lab successfully differentiated PSCs
into gut epithelium in vitro by treating definitive endoderm-specified
cells with Wnt3a and FGF4 to induce posterior endoderm patterning
and hindgut specification (Spence et al., 2011). These conditions
result in the formation of spheroids after 2 days. Then, upon transfer
into Matrigel and incubation in culture conditions that support the
growth of adult-tissue-derived organoids, these PSC-derived
spheroids formed bona-fide small-intestinal organoids. Recently,
these PSC-derived intestinal organoids have been combined with
neural crest cells to recapitulate the normal and functional intestinal
enteric nervous system (Workman et al., 2017; Schlieve et al., 2017).
Gastric organoids
Gastric organoids have been obtained by either expansion of adult
gastric stem cells from both the corpus and the antropyloric
epithelia, as well as from directed differentiation of PSCs. The
identification of Lgr5 as a marker for pyloric stem cells (Barker
et al., 2010) led to the development of the first long-term culture
system of mouse gastric stem cells. Corpus and pylorus stem cells
were grown inMatrigel and in medium supplemented withWNT3A
and FGF10 (Barker et al., 2010; Stange et al., 2013). Blockade of
transforming growth factor-beta (TGFβ) signalling enabled the
expansion of human gastric organoids from both pylorus and corpus
epithelium that would contain all gland and pit cell types (Bartfeld
et al., 2015). Differentiation into acid-producing parietal cells
proved more difficult, though. Only upon co-culture with the
mesenchymal niche, corpus organoids from neonatal (Li et al.,
2014) and adult (Bertaux-Skeirik et al., 2016) mouse stomach tissue
could differentiate into this mature cell type. The human counterpart
has not been achieved, yet.
To obtain PSC-derived gastric organoids, McCracken et al., upon
establishing definitive endoderm with activin (Kubo et al., 2004;
D’Amour et al., 2005), exposed the cells to Wnt, FGF4 and noggin
to enable gastric specification. Noggin is essential to prevent
intestinalization and to promote a foregut fate (McCracken et al.,
2014), while retinoic acid facilitates antrum epithelium specification.
Matrigel is essential for the formation of 3D foregut structures. When
maintained in an EGF-rich medium, these structures generate gastric
organoids that contain all antral epithelium cell types (McCracken
et al., 2014). Noguchi and colleagues used mouse PSCs to generate a
functional corpus epithelium in vitro that contained acid-producing
cells (Noguchi et al., 2015). In a different approach, Wells and
colleagues observed that, after foregut patterning, sustained Wnt
signalling using the GSK3β inhibitor CHIR enabled fundus (corpus)
specification instead of antrum. These fundic cells could be
subsequently differentiated into all cell types of the gastric
epithelium, including functional parietal cells (McCracken et al.,
2017). Interestingly, the authors demonstrate that their
PSC-differentiated fundic organoids contain bona-fide stomach
progenitors that can be isolated, cultured and further propagated in
the tissue-derived organoid medium described by Barker, Huch and
colleagues (Barker et al., 2010) to expand adult-tissue-derived
organoids (McCracken et al., 2017), thus linking, for the first time,
the development of both types of organoids.
Liver organoids
Adult hepatocytes and cholangiocytes (also known as ductal cells)
are the two endodermal-derived cell types in the adult liver, yet the
organ is composed of mesoderm-derived hepatic mesenchymal cells.
Michalopoulos et al. first described liver-derived 3D structures back
in 2001. In these studies, these ‘organoids’ were very different from
what we now consider liver organoid cultures, as they would only
survive for a short period of time in culture, yet they retained some of
the function and structure of the hepatocyte epithelium
(Michalopoulos et al., 2001). It was not until 2013 that the first
liver organoids as we know them now were described. Huch et al.
established the first adult murine-tissue-derived liver organoid culture
that sustains the long-term expansion of liver cells in vitro (Huch
et al., 2013b). By combining Matrigel with hepatocyte growth factor
Box 3. Germ-layer formation: the starting point of
organogenesis
All organs develop from primitive tissues that form at the very early onset
of embryogenesis. After fertilization, cells within the early blastula
establish two main compartments: the extraembryonic tissue, which will
give rise to the supportive foetal environment including placenta and
amniotic sac, and the inner cell mass (ICM), which will give rise to the
embryo proper. Human pluripotent stem cells (PSCs) can be thought of
as roughly equivalent to ICM stem cells, and indeed human ESCs are
taken from the ICM of the human blastocyst. Upon gastrulation, the
embryonic disc, which derives from the ICM, undergoes morphogenetic
movements that establish the three germ layers: endoderm, mesoderm
and ectoderm.
Progenitors within these germ layers have restricted potentials to
generate primordial organ structures, and their specific identity will
depend on their spatial context relative to one another, and onwhere they
lie on the anterior-posterior and dorsal-ventral axes (Zernicka-Goetz and
Hadjantonakis, 2014). This is due to the early establishment of gradients
of morphogens that will influence differentiation towards particular
subregions of these germ layers. For example, the endoderm will give
rise to the entire gastrointestinal tract and, depending on their location,
endodermal progenitors can give rise to more anterior identities, such as
the stomach, or tomore posterior identities, such as the colon. This is due
to an anterior-posterior gradient of signalling factors like Wnt, BMP and
FGFs (Zorn and Wells, 2009).
Similarly, BMP4 promotes formation of the mesendoderm, a precursor
to certain mesoderm and endoderm types, whereas early activation of
Wnt can promote the presomitic mesoderm, the precursor to the kidney
(Little et al., 2016). In contrast, in the absence of growth factors or serum,
the embryoid body tends to be biased towards the ectoderm as the
default. By understanding these specific morphogen gradients and their
effects on the primordial tissue, these growth factors can be provided at
specific concentrations and with specific timing to direct the
differentiation of progenitors towards certain organ identities.
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(HGF), EGF and liver-damage-induced factors FGF (Takase et al.,
2013) and RSPO1 (Huch et al., 2013b), the isolated liver cells self-
organized into 3D structures that retained the ability to differentiate
into functional hepatocyte-like cells, even when grown from a single
cell (Huch et al., 2013b). Addition of an activator of cyclic adenosyl
monophosphate (cAMP) signalling and inhibition of TGFβ
signalling adapted this culture system to the expansion of adult
human liver cells as self-renewing organoids that recapitulate some
function of ex vivo liver tissue (Huch et al., 2015). Of note, both
human and mouse cultures could be established from single cells,
hence enabling, for the first time, the study of mutational processes in
healthy tissue (Huch et al., 2015; Blokzijl et al., 2016).
Takebe et al. took a completely different approach and, by mixing
human induced PSC (iPSC)-derived hepatocytes with mesenchymal
stem cells (MSCs) and umbilical cord cells (HUVECs), obtained the
first embryonic liver bud organoids formed by proliferating
hepatoblasts and supporting cells. When transplanted into different
mouse sites, these developed into mature functional hepatic tissue
(Takebe et al., 2013). In a follow-up study, Takebe and colleagues
also differentiated iPSCs towards the three hepatic progenitors –
hepatic endoderm, endothelium and septum transversum
mesenchyme – hence overcoming the issue of using postnatal
tissue-derived stromal progenitors (Takebe et al., 2017). In 2015,
Sampaziotis et al. also generated cholangiocyte organoids from
iPSCs (Sampaziotis et al., 2015). Whether combining both protocols
could generate structures containing both hepatocytes and
cholangiocytes or whether, instead, a better specification of true
bi-potent hepatoblasts, like the novel Lgr5+ population described by
Prior et al. (2019) is required first to achieve this goal, remains to be
determined.
Since these seminal papers, altered protocols have enabled the
establishment of liver models from different species from rat to dog
(Nantasanti et al., 2015; Kuijk et al., 2016; Kruitwagen et al., 2017),
as well as human disease models ranging from alpha-1-antitrypsin
(A1AT) deficiency and Alagille syndrome (Huch et al., 2015) to
polycystic liver disease (Wills et al., 2016) or cancer (Broutier et al.,
2017; Nuciforo et al., 2018). By modifying the Huch conditions to
expand human organoids (Huch et al., 2015), the Vallier lab has
recently established extrahepatic biliary organoids and showed that
these can form bile-duct-like tubes that can reconstruct the
gallbladder wall upon transplantation into mice (Sampaziotis
et al., 2017a).
Finally, the Nusse and Clevers labs recently reported the
establishment of hepatocyte organoids derived from adult mouse
hepatocytes (Peng et al., 2018; Hu et al., 2018), while the Huch lab
recently established clonal mouse hepatoblast cultures (Prior et al.,
2019). While human adult hepatocyte cultures are yet to be
established, human embryonic cultures that excellently recapitulate
the bile canaliculi structure in vitro have been recently described (Hu
et al., 2018).Whether these cultures can differentiate into more mature
hepatocyte or cholangiocyte derivatives and/or exhibit the extensive
cellular plasticity of the in vivo tissue is still to be investigated.
Pancreatic organoids
Similarly to the liver, both embryonic and/or adult pancreas cells are
difficult to expand or maintain in culture. By isolating mouse
embryonic pancreas progenitors and culturing them in Matrigel,
Grapin-Botton and colleagues elegantly showed that the cells could
recapitulate pancreatic embryonic development in vitro and
generate exocrine (acinar) and endocrine (insulin-producing) cell
derivatives (Greggio et al., 2013). By using a similar culture system
as the adult liver organoids described above, Huch et al. established
the first adult mouse pancreas organoid model by seeding pancreas
ductal cells in Matrigel in the presence of FGF10, noggin, RSPO1
Table 1. Summary of the tissue-derived organoid cultures developed to present
Organ Derived from References
Lung Mouse adult stem cells Lee et al., 2014
Human embryonic progenitors Nikolić et al., 2017
Human adult tissue Sachs et al., 2019
Stomach Mouse adult antrum stem cells Barker et al., 2010
Mouse adult corpus stem cells Stange et al., 2013
Human adult tissue Bartfeld et al., 2015; Li et al., 2014
Liver Mouse adult liver tissue (cholangiocytes) Huch et al., 2013b
Mouse embryonic liver (E10-E13.5) Prior et al., 2019
Human adult liver tissue (cholangiocytes) Huch et al., 2015
Mouse adult liver tissue (hepatocytes) Peng et al., 2018
Human adult hepatocytes and embryonic tissue Hu et al., 2018
Human adult bile duct tissue Sampaziotis et al., 2017b
Pancreas Mouse adult tissue Huch et al., 2013a
Mouse embryonic tissue Greggio et al., 2013
Human adult tissue Loomans et al., 2018
Small intestine Mouse postnatal and adult tissue Ootani et al., 2009
Mouse adult stem cells Sato et al., 2009
Colon Human adult tissue Jung et al., 2011; Li et al., 2014; Sato et al., 2011
Prostate Mouse prostate cells Xin et al., 2007
Human and mouse adult tissue Karthaus et al., 2014
Bone Human bone marrow Kale et al., 2000
Fallopian tube Human adult tissue Kessler et al., 2015
Endometrium Human adult tissue Turco et al., 2017
Mouse and human adult tissue Boretto et al., 2017
Mammary gland Mouse adult tissue Gudjonsson et al., 2002; Dontu et al., 2003
Human adult tissue Linnemann et al., 2015
Salivary gland Human adult tissue Pringle et al., 2016
Mouse adult tissue Maimets et al., 2016
Placenta Human adult tissue Turco et al., 2018
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and EGF (Huch et al., 2013a). A similar system was later applied to
human pancreatic cancer cells (Boj et al., 2015), although long-term
expansion of healthy human pancreas tissue is still to be achieved.
Recently, Loomans et al. expanded human pancreas tissue for a
few passages and obtained structures formed exclusively of
ductal epithelium. After transplantation into mice, these expressed
some endocrine markers, although did not differentiate into islets
(Loomans et al., 2018). Unlike the Grapin-Botton lab’s embryonic
cultures described above, Loomans’ adult-tissue-derived ones
cannot differentiate into endocrine or acinar cells in vitro.
Whether that is because adult pancreas ductal cells have lost their
endocrine differentiation potency or whether the external cues have
not been identified yet is unknown.
Lung organoids
The term ‘lung organoids’ describes both upper- and lower-airway
organoids. Protocols for both PSC- and adult-tissue-derived organoids
have been established. Rossant and colleagues differentiated human
iPSCs to lung epithelium using air-liquid interphase culture (Wong
et al., 2012). This initial protocol was later modified by the Spence lab
to instruct the cells towards a foregut fate by adding TGFβ/BMP
inhibitors, FGF4, and Wnt activators. Subsequent activation of the
Hedgehog pathway with the Smoothened agonist SAG resulted in
lung specification. Transferring these specified 3D spheroids into
Matrigel and culturing them in FGF10-rich medium enabled the
differentiation to lung organoids containing airway-like structures
formed by basal, ciliated and club cells, surrounded by amesenchymal
compartment (Dye et al., 2015). Interestingly, when transplanted in a
bioartificial microporous poly(lactide-co-glycolide) scaffold, full
maturation and differentiation of secretory lineages was observed,
while long-term engraftment enabled these to differentiate into distal
lung cells (Dye et al., 2016). Parallel studies by the Snoeck lab also
showed the formation of 3D structures that developed into branching
airway and early alveolar epithelium after xenotransplantation (Chen
et al., 2017).
Establishing organoids from adult lung tissue has been more
difficult. Hogan and colleagues pioneered upper-airway organoids,
reporting that single basal cells would self-organize into bronchiolar
lung organoid cultures. These had limited expansion potential, yet
were able to differentiate to both basal and luminal cells (Rock et al.,
2009). Building on these cultures, the Rajagopal lab was able to
expand airway basal stem cells by inhibiting SMAD signalling (Mou
et al., 2016). The generation of distal (lower)-airway lung organoids
has been more difficult. Alveoli consist of surfactant-secreting type II
(AT2) and gas-exchanging type I (AT1) cells. By identifying
and expanding bronchioalveolar stem cells (BASCs), Kim and
colleagues showed that single BASCs had bronchiolar and alveolar
differentiation potential in lung organoids co-cultured with lung
endothelial cells (Lee et al., 2014). Similarly, Barkauskas et al., by
co-culturing human AT2 cells with lung fibroblasts, established
self-renewing human alveolar organoids (Barkauskas et al., 2013).
Co-culturing macrophages with AT2 cells promoted the formation of
organoids from AT2 cells (Lechner et al., 2017) in a dose-dependent
manner (i.e. the more macrophages the more AT2 growth).
Only recently, two labs have been able to expand lung
progenitors in the absence of a mesenchymal or endothelial niche:
the Rawlins lab described the first human long-term self-renewing
lung organoids derived from embryonic lung (Nikolic ́ et al., 2017),
while the Clevers lab generated 3D human airway organoids
containing ciliated, goblet, club and basal cells (Sachs et al., 2019).
The generation of self-renewing human alveolar organoids in a
defined medium still awaits development, though.
Thyroid
Although it was well known by the mid-20th century that dissociated
rat thyroid cells aggregate and reconstitute functionally active thyroid
tissue in vitro (Mallette and Anthony, 1966), it was not until very
recently that researchers successfully generated thyroid organoids
from PSCs. This delay was due to the lack of knowledge on how
thyroid tissue develops. By studying the transcription factors
important for thyroid development, Antonica and colleagues found
that forced expression of thyroid-specific transcription factors in PSCs
resulted in thyroid cells that formed follicles in vitro and upon
transplantation (Antonica et al., 2012). More recently, Kotton and
colleagues identified the right combination of BMP and FGF
signalling to enable the differentiation of iPSCs to a thyroid fate.
By isolating these thyroid progenitors and cultivating them in
Matrigel, the authors generated follicular organoids consisting of a
monolayer of hormone-producing thyroid cells. Of note, following
xenotransplantation, these organoids restored TH levels in a
hypothyroid mouse model (Kurmann et al., 2015). Whether self-
renewing human thyroid organoids can be obtained from adult thyroid
epithelium remains to be discovered. In light of the early studies from
Mallette and Anthony and the recent report from Nagano and
colleagues suggesting that mouse thyroid organoids can be developed
from adult tissue (Saito et al., 2018), we speculate that the human
counterpart will soon also be developed.
Mesoderm-derived organoids
The embryonic mesoderm gives rise to a variety of internal organs,
including kidney, heart, cartilage, bone, reproductive organs and
muscle. We detail below the methods to generate the respective
human organoids.
Renal organoids
Kidney organoids are an ideal illustration of the successful generation
of an in vitro model based upon careful characterization of in vivo
development. In particular, several recent studies have begun to shed
light on where the key kidney precursors come from. Work from
Taguchi et al. (2014) was instrumental in characterizing the early
stages ofmetanephric kidney development, particularly the formation
of metanephric mesenchyme (MM), then applying the identified
signalling factors to direct differentiation of mouse and human PSCs
specifically towardsMMcells that could form 3D structures when co-
cultured with mouse tissues. This study helped define the
developmental steps leading to kidney formation.
While Taguchi et al. demonstrated the successful induction of
MM, Takasato et al. (2014) and Xia et al. (2013) described
conditions that would also give rise to the ureteric bud (UB). In both
studies, the authors initially directed PSCs towards the intermediate
mesoderm by first mimicking signalling events involved in
primitive streak formation. In the Xia et al. study, the cells then
gave rise to UB precursors that could mature and integrate into co-
cultures with embryonic mouse kidney. Takasato et al. instead
simultaneously generated human UB and MM identities. Not only
could these cells integrate into embryonic mouse kidney, but they
could also form rudimentary tubule structures upon aggregation
even without the supportive mouse tissue.
The variety of approaches for generating early self-organising
renal structures generally points to important roles for several
growth factors, including BMP4, retinoic acid, FGFs, Wnt and
activin A. However, a breakthrough came with the establishment of
the entirely self-organizing 3D human renal organoids by Takasato
et al. (2015), which involved minimal use of growth factors ( just
CHIR99021 to activate Wnt, and FGF9), and led to structures with
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all the major components of the developing kidney, including the
collecting duct, proximal and distal tubules, glomeruli, and even
endothelial networks.
Bone spheroids
Although proper bone organoids have not yet been established,
Kale et al. described a promising approach to form spheroids
of human adult bone precursor cells (Kale et al., 2000). These are
a heterogeneous population of bone progenitors, including
osteoblasts, that can be induced to form small pieces of crystalline
bone called microspicules. This requires 3D aggregation of the cells
as well as the removal of serum and addition of TGFβ1. Given that
this approach lacks the varied cell types and tissue architecture, it
will be interesting to see whether current improvements in 3D
culture methods could further develop these spheroids to bona-fide
bone organoids.
Fallopian tube organoids
Adult-derived organoid methodology has recently been applied to
the fallopian tube of the female reproductive tract. The method
described (Kessler et al., 2015) has many similarities to the Barker
and Huch et al. stomach organoid method and involves culture of
human adult fallopian tube epithelial cells in Matrigel in the
presence of mouse gastric organoid medium (Barker et al., 2010)
with TGFβ inhibition. The resulting 3D cystic spheres develop
various invaginations as they mature, and contain both ciliated and
secretory cells. These tissues also respond to the sex hormones
estradiol and progesterone in a manner reminiscent of the response
of this tissue in vivo during the menstrual cycle.
Endometrial organoids
Two independent groups have derived organoids from the adult
endometrium using similar conditions as those described for adult
liver organoids (Turco et al., 2017; Boretto et al., 2017). Hence, these
required the presence of RSPO, EGF, FGF10 and noggin, but no
WNT supplementation. Both studies demonstrated that the
endometrial organoids respond to estradiol and progesterone in
specific and differential manners. Specifically, estradiol stimulated
increased proliferation while progesterone stimulated a more mature
morphology, mimicking the later secretory phase of the menstrual
cycle. These morphological and transcriptomic changes recapitulated
the changes in the endometrium during the menstrual cycle.
Furthermore, Turco et al. exposed the endometrial organoids to
pregnancy signals (prolactin, human chorionic gonadotropin and
human placental lactogen), which led to a decidua-like morphology
similar to that seen in early pregnancy.
Ectoderm-derived organoids
The embryonic ectoderm gives rise to two main tissue types: surface
ectoderm, which will develop into skin and its associated glands and
hair; and neural ectoderm, which will give rise to the brain, spinal
cord and neural crest. The neural crest is a highly multipotent entity
that can further differentiate into the peripheral nervous system, as
well as bone, cartilage, connective tissue, and vasculature of the
head, and even contributes to the heart.
Mammary organoids
For decades, mammary cells have been cultured in 3D extracellular
matrix gels as a model for mammary gland development,
homeostasis and tumorigenesis (Hall et al., 1982). Indeed, isolated
mouse mammary epithelial cells were some of the first cells to be
cultured in Matrigel (Li et al., 1987), and could give rise to branched
structures reminiscent of the mammary gland. However, differences
betweenmouse and humanmammary stroma havemade it difficult to
directly translate these methodologies to a human in vitro model.
The first 3D branched mammary-gland-like structures from
human mammary cells were described by Gudjonsson et al. (2002),
who isolated a progenitor population that could generate several cell
types and the typical branched morphology of the mammary gland
when embedded in Matrigel. Similarly, Dontu et al. described the
formation of mature ductal-acinar-like structures from multipotent
human mammary epithelial cells upon embedding in Matrigel and
exposure to prolactin (Dontu et al., 2003). Importantly, these studies
successfully generated mammary-gland-like organoids from cells
first expanded in vitro either as a cell line or in mammospheres.
More recently, researchers devised methods to generate
branching structures directly from isolated human mammary
epithelial cells (Linnemann et al., 2015). The formation of these
structures similarly relies upon embedding in 3Dmatrix gels and the
presence of growth factors, including EGF, hydrocortisone and
insulin, to promote mammary epithelial-stem-cell proliferation.
Under these conditions, and with the addition of forskolin (Fsk),
human mammary epithelial cells spontaneously generated
structures reminiscent of the terminal ductal lobular units of the
mammary gland. Importantly, these structures contained multiple
cell types at correct positions within the branched structure and
showed contractile activity, a feature of the basal/myoepithelial cells
that eject milk during lactation.
Salivary gland
There is some controversy about the developmental origin of the
salivary glands – whether ectodermal or endodermal (see Patel and
Hoffman, 2014 and de Paula et al., 2017 for details), yet mouse
lineage-tracing studies suggest an ectodermal origin (Rothova et al.,
2012), although there is no direct evidence for this yet. By applying the
Clevers organoid method to primary adult salivary gland cells, Coppes
and colleagues efficiently generated long-term-expanding organoids
from themouse (Maimets et al., 2016) and human (Pringle et al., 2016)
salivary gland. The culture conditions required high levels of Wnt
activation to obtain organoids containing all differentiated salivary
gland cell types. Transplantation of these organoids into murine
submandibular glands restored saliva secretion and increased the
number of functional salivary gland acini in vivo (Pringle et al., 2016).
These studies hold the promise of salivary gland transplantation as a
potential treatment for xerostomia (severe hyposalivation).
Retinal organoids
The retina is the neural part of the eye and contains photoreceptors,
supportive cells and interneurons. Self-organizing retinal tissues
were the first entirely 3D neural organoids to be successfully
established from mouse (Eiraku et al., 2011) and later human
(Nakano et al., 2012) ESCs. As with many organoids, Matrigel
turned out to be a key component. Both studies described a very
minimal medium, along with Wnt inhibition, to develop retinal
identities from ESCs. But it was the addition of dissolved Matrigel
that allowed for the formation of a more rigid epithelium that could
adopt the morphology of the retinal primordium, the optic cup.
These optic-cup-like organoids begin as aggregates containing large
spherical vesicles of neuroepithelium with an early retinal identity
and appear similar to optic vesicles. As development proceeds,
these vesicles spontaneously invaginate to from a cup-like
morphology reminiscent of the developing optic cup.
Optic-cup organoids form the typical stratified architecture of the
developing retina, including rods and cones. However, generating
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functional photoreceptors, including light-sensitive outer segments,
has been a challenge. Since the initial description of self-organizing
retinal tissues from human ESCs, others have improved upon these
methods and recently described extended culture times and further
maturation of the photoreceptors to include rudimentary outer-
segment discs and even occasional light responsiveness (Wahlin
et al., 2017).
Brain organoids
In vitromodelling of human brain development has been a fast-evolving
field that builds upon decades of in vivo and ex vivowork. The discovery
in 2001 that human ESCs could form 2D rosette-like structures after an
initial phase of 3D culture as an EB (Zhang et al., 2001) revealed the
self-organization potential of neural progenitors to form neural-tube-like
structures. Eiraku et al. then expanded upon this by extending the initial
3D culture phase before plating on coated dishes, which allowed the
formation of even more complex stratified structures reminiscent of the
developing cerebral cortex (Eiraku et al., 2008; Mariani et al., 2012).
Specifically, neural progenitors could self-organize to form a
continuous neuroepithelium, similar to retinal organoids, but as these
brain-regionalized structures developed, progenitors generated neurons
that properly migrated away from germinal zones to populate a more
basal region reminiscent of the pre-plate of the cerebral cortex. This
germinal zoning and segregation of post-mitotic neurons is highly
reminiscent of the developing human brain.
These initial cultures used dual SMAD and Wnt inhibition
(Watanabe et al., 2005; Eiraku et al., 2008) to promote the formation
of relatively pure neural identities as well as to direct differentiation
towards a telencephalic fate. Subsequent work showed that, in the
absence of these inhibitors, simply providing a very minimal medium
to prevent the expansion of non-neuroectodermal identities could
generate a more broad brain regional identity (Lancaster et al., 2013).
Furthermore, embedding in Matrigel led to a dramatic reorganization
and expansion of the neuroepithelium that allowed the formation of
neural-tube-like buds that further expanded without the need for
replating the aggregates. Like the telencephalic structures described
above, these cerebral organoids developed cortical regions with
characteristic germinal and differentiated zones. However, these 3D
tissues also formed a variety of brain regions, from hindbrain to
retinal identities, within the same organoid. Similarly, maintenance as
a floating aggregate was also applied to the telencephalic structures to
generate 3D forebrain organoids with improved tissue architecture
(Kadoshima et al., 2013).
Since the establishment of telencephalic and cerebral organoids,
subsequent studies further modified these approaches and generated
organoids with more specific brain regional identities, including
cortical spheroids (Pas¸ca et al., 2015), hippocampal organoids
(Sakaguchi et al., 2015), midbrain organoids (Jo et al., 2016),
pituitary and hypothalamic organoids (Suga et al., 2011; Ozone et al.,
2016), and cerebellar organoids (Muguruma et al., 2015). More
recently, researchers fused regionalized brain organoids, revealing
that interneurons generated within the ventral telencephalic region
could indeed migrate to dorsal cortical tissue as they do in vivo (Birey
et al., 2017; Bagley et al., 2017; Xiang et al., 2017). Finally, extended
culture of cerebral organoids resulted in neuron maturation within the
organoid, allowing for the formation of rudimentary networks and
even rare responses to light in thesewhole-brain organoids containing
retinal cells (Quadrato et al., 2017).
Inner-ear organoids
The inner ear develops from non-neural ectoderm and contains
thousands of hair cells that respond to minute air vibrations and thus
allow us to hear, as well as detecting head movements and gravity.
Koehler et al. developed human inner-ear organoids from ESCs by
using Bmp4 to promote the non-neural ectoderm lineage as opposed
to the neural ectoderm (Koehler et al., 2017). However, TGFβ
inhibition prevented unwanted mesoderm and endoderm formation.
This approach led to the successful formation of an epithelium on
the surface of 3D aggregates of ESCs that expressed otic placode
markers, the precursor to the inner ear. Wnt activation subsequently
led to the development of otic vesicles with supportive mesenchyme
and later formation of epithelia-containing sensory hair-like cells.
Disease modelling in organoids
A primary goal of human organoids is their use in modelling human
diseases in order to establish paradigms for drug screening,
genotype-phenotype testing and even biobanking for specific
diseases and future personalized treatments, including cell
therapies. While the establishment of a human organoid model for
most organs is still quite new, and therefore disease modelling in
this manner is still in its infancy, there have already been several
examples of using organoid cultures to study congenital or acquired
human diseases.
Congenital conditions
The first human condition to be modelled in organoids was cystic
fibrosis (CF), in the intestinal organoid system. CF is caused by
mutations in the cystic fibrosis transmembrane conductance
regulator (CFTR) chloride channel, which is normally expressed
in epithelial cells of many organs. Dekkers and colleagues (2013)
generated CF-patient-derived intestinal organoids that could
recapitulate the disease in vitro. They developed a swelling assay
in which wild-type organoids respond to the activation of cAMP by
importing fluid to the lumen and subsequently swelling, whereas
this response is abolished in CF organoids. This approach
demonstrated the excellent predictive value of intestinal organoids
for identification of responders to CFTR modulators, and has
become the first personalized treatment test for CF patients in The
Netherlands (Berkers et al., 2019). In a parallel approach, Vallier
and colleagues also showed that iPSCs from CF patients
differentiated into liver cholangiocytes can also model CF
in vitro, as these cells also lack the ability to swell compared to
wild-type controls (Sampaziotis et al., 2015). In addition, Huch
et al. showed that liver organoids from patients with A1AT
deficiency recapitulated the epithelial features of the disease,
whereby precipitates of the misfolded A1AT protein accumulated in
the differentiated hepatocyte-like cells in vitro (Huch et al., 2015).
Similarly, failure to develop mature biliary cells in liver organoids
from an Alagille syndrome patient mirrored the biliary defects
observed in patients (Huch et al., 2015).
When cerebral organoids were first established, they were also
applied to the study of primary microcephaly, a genetic condition
caused by a mutation in CDK5RAP2 (Lancaster et al., 2013). The
brain organoids generated from patient-derived iPSCs were overall
much smaller and the individual cortical regions were especially
hypoplastic. A series of observations at various time points and
specific examination of mitotic spindle orientation during
progenitor divisions revealed that the patient neural stem cells
began dividing asymmetrically and generating neurons too early,
which led to a depletion of the progenitor pool and an eventual
decrease in overall neuron number. Because mice could not fully
recapitulate the extent of brain-size reduction seen in humans, the
organoids revealed certain morphological differences that could
only be seen in this human-specific model system.
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A modification of the more regionally specified telencephalic
protocol summarized above (Eiraku et al., 2008) was also used to
model a human neurodevelopmental condition, idiopathic autism
spectrum disorder (ASD). Mariani et al., 2015 established iPSC
lines from four ASD patients along with closely related unaffected
controls. These were initially grown as 3D aggregates, followed by
plating of rosettes as described previously (Eiraku et al., 2008;
Mariani et al., 2012), with the modification that rosettes were then
lifted off and grown again as 3D aggregates to yield forebrain
organoids. Although generally very similar between probands and
controls, the ASD organoids displayed an increased number of
inhibitory interneurons as a result of upregulated FoxG1, an
important factor in forebrain patterning. More recently, a genetic
condition causing lissencephaly (smooth brain) was modelled using
forebrain organoids, revealing defects in progenitors, including
mitosis timing, spindle orientation, and defective Wnt signalling
(Bershteyn et al., 2017; Iefremova et al., 2017).
Leber congenital amaurosis is a ciliopathy that affects the retina
and leads to inherited blindness. To model this condition, Parfitt
et al. (2016) generated retinal organoids from iPSCs with a mutation
in CEP290, a known genetic cause of this condition. These
organoids displayed normal initial development into optic cups, but
the resulting tissues showed decreased ciliation and reduced cilia
lengths. By restoring the expression of full-length CEP290, the
authors were able to rescue the cilia length and protein trafficking in
the cilium.
Acquired diseases
Not only can organoids be used to model congenital conditions
from stem cells of patients carrying the genetic mutation, but they
can also be used to model acquired diseases such as those carried by
infectious agents or acquired mutations as in the case of cancer.
Cancer organoids
Since the first report that HeLa cells could be grown in vitro,
researchers have established cancer cell lines for the majority of
tumour types that have facilitated seminal discoveries in cancer
biology. In addition, their ease of culture have made them excellent
for large-scale drug screening and development (Alley et al., 1988),
and have enabled the identification of genomic markers of drug
sensitivity (Garnett et al., 2012). However, they have certain
drawbacks: (1) they lack the tissue architecture of the organ in
question, which is often intimately related to differentiation and
disease progression, (2) their establishment usually requires a strong
cellular selection and (3) they present extensive heterogeneity
between labs, with marked differences in gene expression and
proliferation, and a considerable variability in drug responses (Ben-
David et al., 2018; Hynds et al., 2018). In an attempt to obtain better
models that recapitulate the architecture, genetics and drug
responsiveness of patients’ tumours, patient-derived xenografts
(PDXs) emerged as a very suitable alternative. Unfortunately, they
are not applicable to all cancer models, are expensive and are
impractical for large drug screenings. [For an extended review on
PDXmodels, see Hidalgo et al. (2014).] In that regard, the discovery
that healthy tissue from colon (Jung et al., 2011; Sato et al., 2011)
and stomach (Barker et al., 2010) could be expanded in vitro
prompted many researchers to invest significant effort in using
organoid technology to model cancer for personalized medicine,
drug testing and drug discovery. Indeed, the use of organoids to
model cancer in vitro has become of great interest to the cancer field,
and organoids derived from tissue resections, biopsies or even
circulating tumour cells have now been established (see Table 2 for a
detailed list). In all cases, cancer-derived organoids more faithfully
maintain the genetic and phenotypic features of the tumour of
origin. In that sense, they resemble PDXs, but with the advantage of
a higher establishment success rate, can be easily expanded in vitro
and are amenable for drug screening (Weeber et al., 2017; Pauli
et al., 2017).
The ability to expand primary cancer tissue in a dish has opened up
the possibility of living biobanks of cancer-derived organoid cultures
from different tumour types, including colorectal (van de Wetering
et al., 2015), gastric (Yan et al., 2018), breast (Sachs et al., 2018)
and bladder (Lee et al., 2018; Mullenders et al., 2019) cancer.
These provide opportunities for drug screening as well as drug
development. Hence, organoids from many tissues, ranging from the
ones listed above to liver (Broutier et al., 2017) and oesophageal (Li
et al., 2018) cancer, have proven suitable for large drug-screening
tests. While maintenance of genotypic and phenotypic features as
well as suitability for drug testing does inform us about the
translational potential of cancer organoids, it would be even more
informative to investigate their predictive value in correlating drug-
sensitivity data with clinical or genomic data. Up to today, only two
studies, one in colon (Vlachogiannis et al., 2018) and the other in
bladder (Lee et al., 2018) cancer organoids, have demonstrated the
Table 2. Summary of the cancer-derived organoid cultures developed to present
Organ Derived from References
Lung Human adult tissue and cancer tissue Sachs et al., 2019
Stomach Human healthy and cancer tissue Li et al., 2014
Human healthy and cancer tissue Bartfeld et al., 2015; Seidlitz et al., 2019; Yan et al., 2018
Liver Human cancer tissue Broutier et al., 2017
Human cancer biopsy Nuciforo et al., 2018
Mouse liver cancer Cao et al., 2019
Pancreas Human cancer tissue and biopsy Boj et al., 2015; Seino et al., 2018; Tiriac et al., 2018
Colon Human cancer tissue Li et al., 2014
Human healthy and cancer tissue Sato et al., 2011
Human cancer tissue van de Wetering et al., 2015
Prostate Prostate cancer tissue Gao et al., 2014
Endometrium Human cancer tissue Turco et al., 2017
Mammary Human adult breast cancer tissue Sachs et al., 2018
Bladder Human adult bladder cancer tissue Lee et al., 2018; Mullenders et al., 2019
Oesophagus Human adult oesophageal cancer Li et al., 2018
Barret’s oesophagus Sato et al., 2011
Brain Glioblastoma (no long-term expansion) Hubert et al., 2016
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potential of organoids for predicting patient response. We envision
that these are only the tip of the iceberg of manymore studies to come
to correlate the predictive value of organoids with clinical outcome.
Organoids as models for infectious diseases
Organoids have proven a good model to study infectious diseases
and the mechanisms behind human-specific infectious agents.
Hence, human small-intestinal organoids have been used to model
norovirus (HuNoV) infection and propagation, and have enabled the
identification of bile as a critical factor for HuNoV replication
(Ettayebi et al., 2016). Similarly, Cryptosporidium has been shown
to infect and complete its life cycle in intestinal and lung organoids
(Heo et al., 2018), which has facilitated the identification of not only
type II but also type I interferon signalling as a response to parasite
infection. The ability to use human intestinal organoids to propagate
coronaviruses in vitro has enabled the identification of the small
intestine as an alternative infection route for Middle East respiratory
syndrome coronavirus, which causes severe human respiratory
infections (Zhou et al., 2017a). Similarly, gastric organoids have
been used to develop models of Helicobacter pylori infection
(Bartfeld et al., 2015;McCracken et al., 2014), while lung organoids
have modelled influenza virus infection in vitro (Zhou et al., 2018).
For extended reviews, see Bartfeld (2016), Lanik et al. (2018) and
Dutta et al., 2017.
Along the same lines, cerebral organoids that model genetic
microcephaly were recently adapted by a number of research groups
to study the mechanisms of microcephaly caused by Zika-virus
infection. This area of research has highlighted the power of brain
organoid methods and the ease with which independent investigators
could adopt the technology. Remarkably, initial observations of the
effect of Zika on brain organoids were described as soon as 3 months
after the World Health Organization (WHO) declared Zika a global
health emergency in 2016. These initial reports (Garcez et al., 2016;
Cugola et al., 2016; Qian et al., 2016) described overall smaller sizes
of infected organoids, consistent with the microcephaly seen in
patients, and a specific effect on neural progenitors, leading to cell
death, reduced proliferation and premature differentiation. More
recently, these Zika-infected brain organoids have been used by at
least five independent groups to test treatment strategies that would
prevent the effects of Zika virus infection on neural progenitors
(Watanabe et al., 2017; Zhou et al., 2017b; Sacramento et al., 2017;
Xu et al., 2016; Li et al., 2017). The rapidity with which a completely
new disease model has been established and used for drug testing
speaks to the power and future potential of these in vitromodels for a
variety of disorders.
Gene editing in organoids to improve understanding of human
diseases
The discovery of CRISPR/Cas9 gene editing as a user-friendly
genetic-engineering tool compared to TALEN or zinc-finger
nuclease technologies has prompted many investigators to adapt it
to almost any cell type in any organism (for extended review see
Adli, 2018; Sander and Joung, 2014). The Clevers lab pioneered the
application of CRISPR/Cas9 technology to organoid cultures and
used it to correct mutations and restore the chloride channel function
of CF-patient-derived intestinal organoids (Schwank et al., 2013).
After this seminal paper, many others have highlighted the
technology’s applicability to organoid cultures and its relevance to
further our understanding of human pathologies (see Driehuis and
Clevers, 2017 for an extended review). In particular, gene editing in
colon organoids has enabled the step-wise recapitulation of
tumorigenesis in vitro (Drost et al., 2015; Matano et al., 2015), the
identification of cancer signatures in microsatellite-unstable tumours
(Drost et al., 2017), the discovery of new genes involved in liver
cancer (Artegiani et al., 2019) or even the development of the first
human brain organoid cancer model for primitive neuroectodermal
tumours (Bian et al., 2018).
Future directions and potential therapeutic applications of organoids
While organoids are powerful tools for modelling human
organogenesis, homeostasis, injury repair and disease aetiology,
the technology needs to overcome many hurdles to reach the next
level in modelling human disease. Specifically, because of their
3D nature, the size of all organoids is limited by nutrient supply;
because organoids lack vasculature, their development and growth
depend upon diffusion from the surrounding media. While this is
sufficient for smaller organoids or those without complex
stratification, such as the branched ductal organoids and the
epithelial tissues of the endoderm, the thicker tissues of the brain
experience dramatic necrosis in the organoid interior. Thus,
extensive effort will likely focus on improving nutrient supply and
even vascularization. Some organoids have been implanted into
highly angiogenic sites in rodents to enable vascularization and
blood perfusion by the host (Takebe et al., 2015). This approach
has even revealed that certain human-specific bi-products, for
example liver metabolites, are detectable in the rodent host blood
(Huch et al., 2015; Takebe et al., 2013; Hu et al., 2018).
Furthermore, brain organoids transplanted into a highly
angiogenic site of the rodent brain could be vascularized to
improve survival and attract host-derived microglia (Mansour
et al., 2018). Finally, recent work applying fluid flow to kidney
organoids revealed the ability of endogenous endothelial cells to
form a vascular network and improve the maturation of the kidney
tissue (Homan et al., 2019). This vascularization approach has the
potential to overcome tissue growth/survival limitations while
maintaining in vitro accessibility and scalability.
Another hurdle to disease modelling and drug testing is
the scalability of organoid cultures. Because of their 3D nature
and complex morphologies, organoids are typically examined
using laborious and time-consuming assays such as
immunohistochemistry. Furthermore, their culture requires larger
culture vessels and volumes of media such that it is usually quite
difficult to perform drug testing in the commonly used 384-well
plate format. Thus, other scaling approaches are being developed,
such as mini-spinning bioreactors, or Spin-Ω, for scaling up
production of brain organoids (Qian et al., 2016).
The complexity that arises from their self-organization also
introduces some unpredictability to this model system, particularly
in the case of human PSC-derived organoids. Thus, a desired tissue
identity is not always reproducible, and even when it is present, it
rarely (if ever) arises in the same configuration from organoid to
organoid. This means that researchers using these methods must
carefully control which organoids to use for analysis and must
examine many organoids in order to separate the real phenotype
from the noise of inhomogeneity. However, a number of new
methods have recently been introduced to begin to address this
issue, such as bioengineering methods using scaffolds or
micropatterned substrates that help guide the development of stem
cells to particular identities and morphologies (Warmflash et al.,
2014; Lancaster et al., 2017; Knight et al., 2018).
As discussed above, organoids have proven amenable for drug
testing with relatively small catalogues of drug compounds. More
large-scale drug testing to identify novel compounds that may treat a
range of patients will require scaling up of organoids, and the
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pharmaceutical industry is beginning to investigate this approach.
However, in the more immediate term, organoids could be combined
in the already established arsenal of 2D and bioengineered disease
models. For example, cells generated from organoids could be
isolated and cultured in 2D as a more accessible and scalable source.
Furthermore, organ-on-a-chip approaches may be applied to
organoids, or cells isolated from organoids, in order to capture the
cellular diversity, but in a defined configuration. Microfluidics can
also be applied to organoids to introduce fluid flow or restrict their
growth in defined spatial conformations (Karzbrun et al., 2018).
Finally, even with further improvements, organoids will not replace
existing models in drug development, and should be thought of as
complementary to other methods. In particular, organoids cannot
replace animal models as the in vivo whole-organism context will
remain a necessity when evaluating a particular drug candidate.
Not only could disease model organoids be used for drug testing,
but there is an increasing use of liver organoids and liver-on-a-chip
models to test drug metabolism (Kimura et al., 2018). Since the US
Food and Drug Administration (FDA) now requires drug companies
to demonstrate downstream metabolites before approval, human
in vitro liver models allow for initial testing before testing in patients,
in which potentially unpredicted metabolites could do harm.
Finally, while still far from being a reality, a long-term goal of
organoid technologies will be to apply them to cell replacement or
even whole-organ transplantation. Currently, organ donors are in
short supply andmany patients fail to receive a vital organ transplant
in time. A source of functioning cells or tissues that could replace
the faulty ones in a patient would be a major advance and potentially
save thousands of lives each year. While vast improvements on the
technology are still required to achieve this goal, we envision that
the field might see this type of application, and many others, in the
future.
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Grützmann, K., Sommer, U., Schweitzer, C., Schölch, S., Uhlemann, H.
et al. (2019). Human gastric cancer modelling using organoids. Gut 68, 207-217.
doi:10.1136/gutjnl-2017-314549
Seino, T., Kawasaki, S., Shimokawa, M., Tamagawa, H., Toshimitsu, K., Fujii,
M., Ohta, Y., Matano, M., Nanki, K., Kawasaki, K. et al. (2018). Human
pancreatic tumor organoids reveal loss of stem cell niche factor dependence
during disease progression. Cell Stem Cell 22, 454-467.e6. doi:10.1016/j.stem.
2017.12.009
Smith, E. and Cochrane, W. J. (1946). Cystic organoid teratoma: (Report of a
Case). Can. Med. Assoc. J. 55, 151-152.
Spence, J. R., Mayhew, C. N., Rankin, S. A., Kuhar, M. F., Vallance, J. E., Tolle,
K., Hoskins, E. E., Kalinichenko, V. V., Wells, S. I., Zorn, A. M. et al. (2011).
Directed differentiation of human pluripotent stem cells into intestinal tissue in
vitro. Nature 470, 105-109. doi:10.1038/nature09691
Stange, D. E., Koo, B.-K., Huch, M., Sibbel, G., Basak, O., Lyubimova, A.,
Kujala, P., Bartfeld, S., Koster, J., Geahlen, J. H. et al. (2013). Differentiated
Troy+ chief cells act as reserve stem cells to generate all lineages of the stomach
epithelium. Cell 155, 357-368. doi:10.1016/j.cell.2013.09.008
Suga, H., Kadoshima, T., Minaguchi, M., Ohgushi, M., Soen, M., Nakano, T.,
Takata, N., Wataya, T., Muguruma, K., Miyoshi, H. et al. (2011). Self-formation
of functional adenohypophysis in three-dimensional culture. Nature 480, 57-62.
doi:10.1038/nature10637
Taguchi, A., Kaku, Y., Ohmori, T., Sharmin, S., Ogawa, M., Sasaki, H. and
Nishinakamura, R. (2014). Redefining the in vivo origin of metanephric nephron
progenitors enables generation of complex kidney structures from pluripotent
stem cells. Cell Stem Cell 14, 53-67. doi:10.1016/j.stem.2013.11.010
Takasato, M., Er, P. X., Becroft, M., Vanslambrouck, J. M., Stanley, E. G.,
Elefanty, A. G. and Little, M. H. (2014). Directing human embryonic stem cell
differentiation towards a renal lineage generates a self-organizing kidney. Nat.
Cell Biol. 16, 118-126. doi:10.1038/ncb2894
Takasato, M., Er, P. X., Chiu, H. S., Maier, B., Baillie, G. J., Ferguson, C., Parton,
R. G., Wolvetang, E. J., Roost, M. S., Chuva de Sousa Lopes, S. M. and et al.
(2015). Kidney organoids from human iPS cells contain multiple lineages and
model human nephrogenesis. Nature 526, 564-568. doi:10.1038/nature15695
Takase, H. M., Itoh, T., Ino, S., Wang, T., Koji, T., Akira, S., Takikawa, Y. and
Miyajima, A. (2013). FGF7 is a functional niche signal required for stimulation of
adult liver progenitor cells that support liver regeneration. Genes Dev. 27,
169-181. doi:10.1101/gad.204776.112
Takebe, T., Sekine, K., Enomura, M., Koike, H., Kimura, M., Ogaeri, T., Zhang,
R.-R., Ueno, Y., Zheng, Y.-W., Koike, N. et al. (2013). Vascularized and
functional human liver from an IPSC-derived organ bud transplant. Nature 499,
481-484. doi:10.1038/nature12271
Takebe, T., Enomura, M., Yoshizawa, E., Kimura, M., Koike, H., Ueno, Y.,
Matsuzaki, T., Yamazaki, T., Toyohara, T., Osafune, K. et al. (2015).
Vascularized and complex organ buds from diverse tissues via mesenchymal
cell-driven condensation. Cell Stem Cell 16, 556-565. doi:10.1016/j.stem.2015.
03.004
Takebe, T., Sekine, K., Kimura, M., Yoshizawa, E., Ayano, S., Koido, M.,
Funayama, S., Nakanishi, N., Hisai, T., Kobayashi, T. et al. (2017). Massive and
reproducible production of liver buds entirely from human pluripotent stem cells.
Cell Rep. 21, 2661-2670. doi:10.1016/j.celrep.2017.11.005
Tiriac, H., Bucobo, J. C., Tzimas, D., Grewel, S., Lacomb, J. F., Rowehl, L. M.,
Nagula, S., Wu, M., Kim, J., Sasson, A. et al. (2018). Successful creation of
pancreatic cancer organoids by means of Eus-guided fine-needle biopsy
sampling for personalized cancer treatment. Gastrointest. Endosc. 87,
1474-1480. doi:10.1016/j.gie.2017.12.032
Turco, M. Y., Gardner, L., Hughes, J., Cindrova-Davies, T., Gomez, M. J., Farrell,
L., Hollinshead, M., Marsh, S. G. E., Brosens, J. J., Critchley, H. O. et al.
(2017). Long-term, hormone-responsive organoid cultures of human
endometrium in a chemically defined medium. Nat. Cell Biol. 19, 568-577.
doi:10.1038/ncb3516
Turco, M. Y., Gardner, L., Kay, R. G., Hamilton, R. S., Prater, M., Hollinshead,
M. S., Mcwhinnie, A., Esposito, L., Fernando, R., Skelton, H. et al. (2018).
Trophoblast organoids as a model for maternal-fetal interactions during human
placentation. Nature 564, 263-267. doi:10.1038/s41586-018-0753-3
van de Wetering, M., Francies, H. E., Francis, J. M., Bounova, G., Iorio, F.,
Pronk, A., van Houdt, W., van Gorp, J., Taylor-Weiner, A., Kester, L. et al.
(2015). Prospective derivation of a living organoid biobank of colorectal cancer
patients. Cell 161, 933-945. doi:10.1016/j.cell.2015.03.053
Vlachogiannis, G., Hedayat, S., Vatsiou, A., Jamin, Y., Fernández-Mateos, J.,
Khan, K., Lampis, A., Eason, K., Huntingford, I., Burke, R. et al. (2018).
13
AT A GLANCE Disease Models & Mechanisms (2019) 12, dmm039347. doi:10.1242/dmm.039347
D
is
ea
se
M
o
d
el
s
&
M
ec
h
an
is
m
s
Patient-derived organoids model treatment response of metastatic
gastrointestinal cancers. Science 359, 920-926. doi:10.1126/science.aao2774
Wahlin, K. J., Maruotti, J. A., Sripathi, S. R., Ball, J., Angueyra, J. M., Kim, C.,
Grebe, R., Li, W., Jones, B. W. and Zack, D. J. (2017). photoreceptor outer
segment-like structures in long-term 3D retinas from human pluripotent stem cells.
Sci. Rep. 7, 766. doi:10.1038/s41598-017-00774-9
Warmflash, A., Sorre, B., Etoc, F., Siggia, E. D. and Brivanlou, A. H. (2014). A
method to recapitulate early embryonic spatial patterning in human embryonic
stem cells. Nat. Methods 11, 847-854. doi:10.1038/nmeth.3016
Watanabe, K., Kamiya, D., Nishiyama, A., Katayama, T., Nozaki, S., Kawasaki,
H., Watanabe, Y., Mizuseki, K. and Sasai, Y. (2005). Directed differentiation of
telencephalic precursors from embryonic stem cells. Nat. Neurosci. 8, 288-296.
doi:10.1038/nn1402
Watanabe, M., Buth, J. E., Vishlaghi, N., de la Torre-Ubieta, L., Taxidis, J.,
Khakh, B. S., Coppola, G., Pearson, C. A., Yamauchi, K., Gong, D. et al.
(2017). Self-organized cerebral organoids with human-specific features predict
effective drugs to combat Zika virus infection. Cell Rep. 21, 517-532. doi:10.1016/
j.celrep.2017.09.047
Weeber, F., Ooft, S. N., Dijkstra, K. K. and Voest, E. E. (2017). Tumor organoids as
a pre-clinical cancer model for drug discovery. Cell Chem. Biol. 24, 1092-1100.
doi:10.1016/j.chembiol.2017.06.012
Wills, E. S., Cnossen, W. R., Veltman, J. A., Woestenenk, R., Steehouwer, M.,
Salomon, J., te Morsche, R. H. M., Huch, M., Hehir-Kwa, J. Y., Banning, M. J.
et al. (2016). Chromosomal abnormalities in hepatic cysts point to novel
polycystic liver disease genes. Eur. J. Hum. Genet. 24, 1707-1714. doi:10.1038/
ejhg.2016.97
Wong, A. P., Bear, C. E., Chin, S., Pasceri, P., Thompson, T. O., Huan, L.-J.,
Ratjen, F., Ellis, J. and Rossant, J. (2012). Directed differentiation of human
pluripotent stem cells into mature airway epithelia expressing functional CFTR
protein. Nat. Biotechnol. 30, 876-882. doi:10.1038/nbt.2328
Workman,M. J., Mahe, M.M., Trisno, S., Poling, H. M.,Watson, C. L., Sundaram,
N., Chang, C.-F., Schiesser, J., Aubert, P., Stanley, E. G. et al. (2017).
Engineered human pluripotent-stem-cell-derived intestinal tissues with a
functional enteric nervous system. Nat. Med. 23, 49-59. doi:10.1038/nm.4233
Xia, Y., Nivet, E., Sancho-Martinez, I., Gallegos, T., Suzuki, K., Okamura, D., Wu,
M.-Z., Dubova, I., Esteban, C. R., Montserrat, N. et al. (2013). Directed
differentiation of human pluripotent cells to ureteric bud kidney progenitor-like
cells. Nat. Cell Biol. 15, 1507-1515. doi:10.1038/ncb2872
Xiang, Y., Tanaka, Y., Patterson, B., Kang, Y.-J., Govindaiah, G., Roselaar, N.,
Cakir, B., Kim, K.-Y., Lombroso, A. P., Hwang, S.-M. et al. (2017). Fusion of
regionally specified HPSC-derived organoids models human brain development
and interneuron migration. Cell Stem Cell 21, 383-398.e7. doi:10.1016/j.stem.
2017.07.007
Xin, L., Lukacs, R. U., Lawson, D. A., Cheng, D. and Witte, O. N. (2007). Self-
renewal and multilineage differentiation in vitro from murine prostate stem cells.
Stem Cells 25, 2760-2769. doi:10.1634/stemcells.2007-0355
Xu, M., Lee, E. M., Wen, Z., Cheng, Y., Huang, W.-K., Qian, X., Tcw, J.,
Kouznetsova, J., Ogden, S. C., Hammack, C. et al. (2016). Identification of
small-molecule inhibitors of Zika virus infection and induced neural cell death via a
drug repurposing screen. Nat. Med. 22, 1101-1107. doi:10.1038/nm.4184
Yan, H. H. N., Siu, H. C., Law, S., Ho, S. L., Yue, S. S. K., Tsui, W. Y., Chan, D.,
Chan, A. S., Ma, S., Lam, K. O. et al. (2018). A comprehensive human gastric
cancer organoid biobank captures tumor subtype heterogeneity and enables
therapeutic screening. Cell Stem Cell 23, 882-897.e11. doi:10.1016/j.stem.2018.
09.016
Zernicka-Goetz, M. and Hadjantonakis, A.-K. (2014). From pluripotency to
differentiation: laying foundations for the body pattern in the mouse embryo.
Philos. Trans. R. Soc. Lond. B Biol. Sci. 369. doi:10.1098/rstb.2013.0535
Zhang, S.-C.,Wernig, M., Duncan, I. D., Brüstle, O. and Thomson, J. A. (2001). In
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